Suchergebnisse - "0049-8254" OR "1366-5928"

PubPharm (7)

1

Species differences in plasma protein binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease inhibitor nirmatrelvir

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2023

von Greenfield, S. | Eng, H. | Yang, Q. | +6

2

Potential application of mass spectrometry imaging in pharmacokinetic studies

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2022

von Nwabufo, C. | Aigbogun, O.

3

Potential application of mass spectrometry imaging in pharmacokinetic studies

enthalten in: Xenobiotica | 2022

von Nwabufo, C. | Aigbogun, O.

4

Colchicine for the treatment of COVID-19 patients : efficacy, safety, and model informed dosage regimens

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2021

von Karatza, E. | Ismailos, G. | Karalis, V.

5

Optimization of hydroxychloroquine dosing scheme based on COVID-19 patients' characteristics : a review of the literature and simulations

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2021

von Karatza, E. | Ismailos, G. | Marangos, M. | +1

6

Optimization of hydroxychloroquine dosing scheme based on COVID-19 patients’ characteristics: a review of the literature and simulations

enthalten in: Xenobiotica | 2021

von Karatza, E. | Ismailos, G. | Marangos, M. | +1

7

Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens

enthalten in: Xenobiotica | 2021

von Karatza, E. | Ismailos, G. | Karalis, V.

1
[1]